The Government of Alberta achieved an important milestone yesterday by announcing the expansion of public coverage of continuous glucose monitors (CGMs) to all ages, removing the existing age cap. Prior to this announcement, public coverage of CGMs in Alberta did not extend beyond age 18. It is estimated that over 30,000 people live with T1D […]
We are now Breakthrough T1D™ – the organization formerly known as JDRF Canada rebrands to recognize impact of type 1 diabetes on Canadians of all ages
The leading type 1 diabetes (T1D) research and advocacy organization unveils its new identity to better reflect the community it serves while working to accelerate breakthroughs in T1D research TORONTO, ON, November 1, 2024 – Breakthrough T1D Canada, formerly JDRF Canada, is proud to announce its brand relaunch, featuring a new name and refreshed visual […]
A joint response to Bill C-64, An Act Respecting Pharmacare, receiving Royal Assent from JDRF Canada and Diabetes Canada.
Ottawa, ON (October 11, 2024) – For the more than four million people living with diabetes in Canada, access to affordable medications is critical. As Bill C-64, An Act Respecting Pharmacare, received Royal Assent, we applaud the Government of Canada for taking the initial steps towards the development of a plan to provide coverage for a […]
Research Canada Recognizes Three Champions of Health Research Advocacy
OTTAWA, September 26, 2024 – Research Canada is pleased to announce the 2024 Leadership in Advocacy Awardees. 2024 Leadership in Advocacy Awardee: Dr. Leena Augimeri, a Children/Youth Mental Wellness and Crime Prevention Specialist & Innovator, the Chair of the Ontario Youth Justice Task Force, Adjunct Professor at the University of Toronto and the Co-Founder of SNAP […]
JDRF Walk to Cure Diabetes
TORONTO, ON — May 31, 2024 – Throughout June close to 50 communities will be gathering across Canada to raise funds for type 1 diabetes research The JDRF Walk to Cure Diabetes is the largest fundraising event in Canada that brings together the type 1 diabetes (T1D) community to raise funds for T1D research. A […]
Newfoundland and Labrador expands access to continuous glucose monitoring program
March 21, 2024 – Newfoundland and Labrador – Through Budget 2024, the Government of Newfoundland & Labrador is expanding its continuous glucose monitoring program to include patients with type 1 diabetes (T1D) up to the age of 25 who are enrolled in the NL Insulin Pump Program and those who are pregnant with gestational diabetes. […]
JDRF Proudly Announces the Appointment of New International Board of Directors Vice Chair
Matt Varey of Ontario is the first Canadian to serve as Vice Chair on the board of the global type 1 diabetes non-profit New York and Toronto, March 13, 2024 — JDRF, the leading global type 1 diabetes (T1D), research and advocacy organization, today announced the appointment of Matt Varey as the new vice chair […]
Canadians living with type 1 diabetes will have improved access to the treatments and devices they need through a new national pharmacare program
February 29, 2024 – Ottawa – Today marks a historic moment for the type 1 diabetes (T1D) community in Canada. JDRF Canada is thrilled to have been part of the Government of Canada’s announcement of a new national pharmacare program. The organization commends the federal government for ensuring the close to 300,000 Canadians living with […]
Nova Scotia announces expanded coverage for insulin pumps and advanced glucose monitoring
February 28, 2024 – Halifax – The Government of Nova Scotia announced a historic investment to provide better access to diabetes devices such as insulin pumps and glucose monitors for Nova Scotians with diabetes. The province will be investing $5.9 million to fund sensor-based glucose monitoring supplies, and $1.3 million to expand the Nova Scotia […]
Ensuring Canadians living with diabetes have access to the treatments and devices they need in Canada’s national pharmacare program
February 27, 2024 – Canada-wide – JDRF Canada, an organization dedicated to improving the lives of the estimated 300,000 Canadians living with type 1 diabetes (T1D) through its advocacy efforts, is awaiting the imminent announcement of a new national pharmacare program that will include coverage of diabetes medications. Insulin was discovered in Canada by Banting, […]
CIHR Research Excellence, Diversity, and Independence (REDI) Early Career Transition Awards Announced
These awards support the career development of the next generation of health researchers. The REDI awards are available to post-doctoral researchers, clinicians, and research associates from specific underrepresented groups to help them launch their research faculty careers in Canada. The 2023 awards were open only to Black people and racialized women, which previous research identified […]
JDRF Canada Op-Ed in the Hill Times, February 14, 2024
OPINION: Canada is on track to cure type 1 diabetes. With the right support, we can get there. Research innovation is becoming increasingly competitive in the post-pandemic world and Canada is at risk of losing its foothold. An estimated 300,000 Canadians (growing at a rate of 4.4% per year) live with type 1 diabetes (T1D), […]
